Active Surveillance Cultures for Multidrug Resistant Gram-Negative Organisms at an Acute Care Hospital

CompletedOBSERVATIONAL
Enrollment

2,878

Participants

Timeline

Start Date

February 12, 2015

Primary Completion Date

March 31, 2019

Study Completion Date

March 31, 2019

Conditions
Infection
Interventions
OTHER

review of surveillance cultures within the past year

"ASC results are reported as positive or negative based on the culture source. Antimicrobial susceptibility testing is performed but not reported; however, physicians may obtain susceptibility information for MDR GNB only if clinically indicated through the microbiology department.~1. Nasal swab for MRSA~2. Respiratory specimens~i. Sputum for MRSA, VRE, and Multi Drug Resistant gram-negative Bacteria (MDR GNB) (if not intubated but with productive cough) ii. Endotracheal aspirate for MRSA, VRE, and MDR GNB (if intubated) c. Drainage from any wounds for MRSA, VRE, and MDR GNB d. Rectal/ perianal swab for VRE, and MDR GNB e. Urine for MRSA, VRE, and MDR GNB (from patients catheterized prior to admission only)"

All Listed Sponsors
lead

Methodist Health System

OTHER

NCT04715464 - Active Surveillance Cultures for Multidrug Resistant Gram-Negative Organisms at an Acute Care Hospital | Biotech Hunter | Biotech Hunter